BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-1168. [PMID: 10202167 DOI: 10.1056/nejm199904153401504] [Cited by in Crossref: 413] [Cited by in F6Publishing: 71] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Zeymer U, Hochadel M, Hauptmann KE, Wiegand K, Schuhmacher B, Brachmann J, Gitt A, Zahn R. Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. Clin Res Cardiol 2013;102:223-7. [PMID: 23179136 DOI: 10.1007/s00392-012-0523-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
2 Ducas J, Grech ED. ABC of interventional cardiology. Percutaneous coronary intervention: cardiogenic shock. BMJ 2003;326:1450-2. [PMID: 12829561 DOI: 10.1136/bmj.326.7404.1450] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Salem R, Mebazaa A. Nitric oxide inhibition rapidly increases blood pressure with no change in outcome in cardiogenic shock: the TRIUMPH trial. Crit Care 2007;11:136. [PMID: 17561988 DOI: 10.1186/cc5925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35:1397-1405. [PMID: 19506833 DOI: 10.1007/s00134-009-1508-2] [Cited by in Crossref: 126] [Cited by in F6Publishing: 98] [Article Influence: 10.5] [Reference Citation Analysis]
5 Baljepally R, Tahir H. Effect of Atrioventricular Dyssynchrony on Impella Hemodynamics: Mechanism and Its Clinical Implications. Cardiol Res 2021;12:219-24. [PMID: 34349862 DOI: 10.14740/cr1287] [Reference Citation Analysis]
6 Islam MS, Panduranga P, Al-Mukhaini M, Al-Riyami A, El-Deeb M, Rahman SA, Al-Riyami MB. In-Hospital Outcome of Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Results from Royal Hospital Percutaneous Coronary Intervention Registry, Oman. Oman Med J 2016;31:46-51. [PMID: 26814946 DOI: 10.5001/omj.2016.09] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Victor SM, Gnanaraj A, S V, Deshmukh R, Kandasamy M, Janakiraman E, Pandurangi UM, Latchumanadhas K, Abraham G, Mullasari AS. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention. Indian Heart J 2014;66:517-24. [PMID: 25443605 DOI: 10.1016/j.ihj.2014.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
8 Lee MS, Tseng CH, Barker CM, Menon V, Steckman D, Shemin R, Hochman JS. Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease. Ann Thorac Surg 2008;86:29-34. [PMID: 18573394 DOI: 10.1016/j.athoracsur.2008.03.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
9 Goldberg RJ, Kramer DG, Yarzebski J, Lessard D, Gore JM. Prehospital transport of patients with acute myocardial infarction: a community-wide perspective. Heart Lung 2008;37:266-74. [PMID: 18620102 DOI: 10.1016/j.hrtlng.2007.05.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Fiechter D, Kats S, Brands R, van Middelaar B, Pasterkamp G, de Kleijn D, Seinen W. Bovine Intestinal Alkaline Phosphatase Reduces Inflammation After Induction of Acute Myocardial Infarction in Mice. Cardiol Res 2011;2:236-42. [PMID: 28357012 DOI: 10.4021/cr81w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Gjesdal G, Braun OÖ, Smith JG, Scherstén F, Tydén P. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock. BMC Cardiovasc Disord 2018;18:8. [PMID: 29347907 DOI: 10.1186/s12872-018-0744-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Hariri E, Tisminetzky M, Lessard D, Yarzebski J, Gore J, Goldberg R. Twenty-Five-Year (1986-2011) Trends in the Incidence and Death Rates of Stroke Complicating Acute Myocardial Infarction. Am J Med 2018;131:1086-94. [PMID: 29730362 DOI: 10.1016/j.amjmed.2018.04.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
13 Roger VL. Severity of myocardial infarction: new insights on an elusive construct. Circulation. 2009;119:489-491. [PMID: 19188517 DOI: 10.1161/circulationaha.108.829663] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
14 Kiatchoosakun S, Wongwipaporn C, Pussadhamma B. Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Asia 2016;8:13-7. [PMID: 27347008 DOI: 10.1136/heartasia-2015-010715] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
15 Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511-2515. [PMID: 16757723 DOI: 10.1001/jama.295.21.2511] [Cited by in Crossref: 439] [Cited by in F6Publishing: 279] [Article Influence: 29.3] [Reference Citation Analysis]
16 Nguyen HL, Saczynski JS, Gore JM, Waring ME, Lessard D, Yarzebski J, Reed G, Spencer FA, Li SX, Goldberg RJ. Long-term trends in short-term outcomes in acute myocardial infarction. Am J Med 2011;124:939-46. [PMID: 21962314 DOI: 10.1016/j.amjmed.2011.05.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
17 Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007;91:537–552. [PMID: 17640535 DOI: 10.1016/j.mcna.2007.03.007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
18 Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavík V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J 2010;160:443-50. [PMID: 20826251 DOI: 10.1016/j.ahj.2010.06.024] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 7.9] [Reference Citation Analysis]
19 Menon V, Hochman JS. Management of cardiogenic shock complicating acute myocardial infarction. Heart 2002;88:531-7. [PMID: 12381652 DOI: 10.1136/heart.88.5.531] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
20 Zavalichi MA, Nistor I, Nedelcu AE, Zavalichi SD, Georgescu CMA, Stătescu C, Covic A. Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review. Biomed Res Int 2020;2020:6126534. [PMID: 32382560 DOI: 10.1155/2020/6126534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
21 Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014;40:1795-815. [PMID: 25392034 DOI: 10.1007/s00134-014-3525-z] [Cited by in Crossref: 720] [Cited by in F6Publishing: 593] [Article Influence: 102.9] [Reference Citation Analysis]
22 Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider DG, Zauner C, Heinz G, Schellongowski P, Kluge S, Trauner M, Fuhrmann V. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Ann Intensive Care 2016;6:61. [PMID: 27392655 DOI: 10.1186/s13613-016-0162-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
23 Prondzinsky R, Lemm H, Geppert A, Buerke M, Russ M, Werdan K. [Infarct-related cardiogenic shock : Prognosis and treatment]. Med Klin Intensivmed Notfmed 2018;113:267-76. [PMID: 29721682 DOI: 10.1007/s00063-018-0428-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Bae EH, Lim SY, Jeong MH, Park HW, Lim JH, Hong YJ, Kim W, Kim JH, Cho JG, Ahn YK, Park JC, Suh SP, Ahn BH, Kim SH, Kang JC. Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock. Korean J Intern Med 2005;20:8-14. [PMID: 15906947 DOI: 10.3904/kjim.2005.20.1.8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos JA, Yannopoulos D. Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock. Front Cardiovasc Med 2021;8:686558. [PMID: 34307500 DOI: 10.3389/fcvm.2021.686558] [Reference Citation Analysis]
26 Cook S, Windecker S. Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions. Curr Cardiol Rep 2009;11:369-76. [PMID: 19709497 DOI: 10.1007/s11886-009-0051-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
27 Williams SG, Wright DJ, Tan LB. Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice. Heart 2000;83:621-6. [PMID: 10814616 DOI: 10.1136/heart.83.6.621] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
28 Dharma S, Dakota I, Firdaus I, Wardeh AJ, Jukema JW. The Use of Intra-aortic Balloon Pump in a Real-World Setting: A Comparison between Survivors and Nonsurvivors from Acute Coronary Syndrome Treated with IABP. The Jakarta Acute Coronary Syndrome Registry. Int J Angiol 2013;22:213-22. [PMID: 24436615 DOI: 10.1055/s-0033-1348884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Pöss J, Mahfoud F, Seiler S, Heine GH, Fliser D, Böhm M, Link A. FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2013;2:211-8. [PMID: 24222832 DOI: 10.1177/2048872613494025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
30 Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, Maroulidis G, Nanas SN, Kanakakis J, Nanas JN. Long-term survival and outcomes after hospitalization for acute myocardial infarction complicated by cardiogenic shock. Clin Cardiol 2009;32:E4-8. [PMID: 19455673 DOI: 10.1002/clc.20488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 Venkatason P, Zubairi YZ, Wan Ahmad WA, Hafidz MI, Ismail MD, Hadi MF, Zuhdi ASM. In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry. BMJ Open 2019;9:e025734. [PMID: 31061031 DOI: 10.1136/bmjopen-2018-025734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Jeger RV, Urban P, Harkness SM, Tseng CH, Stauffer JC, Lejemtel TH, Sleeper LA, Pfisterer ME, Hochman JS. Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials. Acute Card Care 2011;13:14-20. [PMID: 21244231 DOI: 10.3109/17482941.2010.538696] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
33 Roger VL, Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, Bell MR, Kors J, Yawn BP, Jacobsen SJ. Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation. 2010;121:863-869. [PMID: 20142444 DOI: 10.1161/circulationaha.109.897249] [Cited by in Crossref: 240] [Cited by in F6Publishing: 133] [Article Influence: 21.8] [Reference Citation Analysis]
34 Nguyen HL, Yarzebski J, Lessard D, Gore JM, McManus DD, Goldberg RJ. Ten-Year (2001-2011) Trends in the Incidence Rates and Short-Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction. J Am Heart Assoc 2017;6:e005566. [PMID: 28592462 DOI: 10.1161/JAHA.117.005566] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
35 Saczynski JS, McManus D, Zhou Z, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol 2009;104:169-74. [PMID: 19576341 DOI: 10.1016/j.amjcard.2009.03.011] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]
36 Weir RA, McMurray JJ. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep 2006;3:175-80. [PMID: 17129511 DOI: 10.1007/s11897-006-0019-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
37 Yoshida H, Sakakura K, Yamamoto K, Taniguchi Y, Tsukui T, Seguchi M, Jinnouchi H, Wada H, Moriya T, Fujita H. Comparison of in-hospital death following ST-elevation myocardial infarction between secondary emergency and tertiary emergency. Cardiovasc Interv Ther 2020. [PMID: 32862370 DOI: 10.1007/s12928-020-00698-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Saczynski JS, Spencer FA, Gore JM, Gurwitz JH, Yarzebski J, Lessard D, Goldberg RJ. Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med 2008;168:2104-10. [PMID: 18955639 DOI: 10.1001/archinte.168.19.2104] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
39 Joffe SW, Chalian A, Tighe DA, Aurigemma GP, Yarzebski J, Gore JM, Lessard D, Goldberg RJ. Trends in the use of echocardiography and left ventriculography to assess left ventricular ejection fraction in patients hospitalized with acute myocardial infarction. Am Heart J 2009;158:185-92. [PMID: 19619693 DOI: 10.1016/j.ahj.2009.05.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Iqbal MB, Robinson SD, Ding L, Fung A, Aymong E, Chan AW, Hodge S, Della Siega A, Nadra IJ; British Columbia Cardiac Registry Investigators. Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry. PLoS One 2016;11:e0148931. [PMID: 26870950 DOI: 10.1371/journal.pone.0148931] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
41 Kim Y, Cho YH, Yang JH, Sung K, Lee YT, Kim WS, Lee H, Cho SH. Outcomes of Coronary Artery Bypass Grafting after Extracorporeal Life Support in Patients with Cardiac Arrest or Cardiogenic Shock. Korean J Thorac Cardiovasc Surg 2019;52:70-7. [PMID: 31089443 DOI: 10.5090/kjtcs.2019.52.2.70] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ford ES, Roger VL, Dunlay SM, Go AS, Rosamond WD. Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States. J Am Heart Assoc 2014;3:e001097. [PMID: 25472744 DOI: 10.1161/JAHA.114.001097] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
43 Antonelli M, Levy M, Andrews PJ, Chastre J, Hudson LD, Manthous C, Meduri GU, Moreno RP, Putensen C, Stewart T. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med. 2007;33:575-590. [PMID: 17285286 DOI: 10.1007/s00134-007-0531-4] [Cited by in Crossref: 315] [Cited by in F6Publishing: 242] [Article Influence: 22.5] [Reference Citation Analysis]
44 McManus DD, Huang W, Domakonda KV, Ward J, Saczysnki JS, Gore JM, Goldberg RJ. Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome. Am J Med 2012;125:1076-84. [PMID: 23098864 DOI: 10.1016/j.amjmed.2012.05.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
45 Floyd KC, Yarzebski J, Spencer FA, Lessard D, Dalen JE, Alpert JS, Gore JM, Goldberg RJ. A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes 2009;2:88-95. [PMID: 20031820 DOI: 10.1161/CIRCOUTCOMES.108.811828] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
46 Suleiman T, Scott A, Tong D, Khanna V, Kunadian V. Contemporary device management of cardiogenic shock following acute myocardial infarction. Heart Fail Rev 2021. [PMID: 33655387 DOI: 10.1007/s10741-021-10088-8] [Reference Citation Analysis]
47 Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, Fedele F, Fonarow GC, Maggioni AP, Mebazaa A, Mehra M, Metra M, Nodari S, Pang PS, Ponikowski P, Sabbah HN, Komajda M, Butler J. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev 2013;18:107-22. [PMID: 22581217 DOI: 10.1007/s10741-012-9315-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
48 Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 2018;1:CD009669. [PMID: 29376560 DOI: 10.1002/14651858.CD009669.pub3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
49 Harrold LR, Esteban J, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Narrowing gender differences in procedure use for acute myocardial infarction: insights from the Worcester heart attack study. J Gen Intern Med 2003;18:423-31. [PMID: 12823649 DOI: 10.1046/j.1525-1497.2003.20929.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
50 Deng F, Xia Y, Fu M, Hu Y, Jia F, Rahardjo Y, Duan Y, He L, Chang J. Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China. Exp Ther Med 2016;11:2127-38. [PMID: 27284294 DOI: 10.3892/etm.2016.3211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 Mayich J, Cox JL, Buth KJ, Légaré JF. Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock. Can J Cardiol 2006;22:331-5. [PMID: 16568158 DOI: 10.1016/s0828-282x(06)70918-7] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Omerovic E, Råmunddal T, Albertsson P, Holmberg M, Hallgren P, Boren J, Grip L, Matejka G. Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction. Vasc Health Risk Manag 2010;6:657-63. [PMID: 20859537 DOI: 10.2147/vhrm.s8856] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
53 Ramanathan K, Farkouh ME, Cosmi JE, French JK, Harkness SM, Džavík V, Sleeper LA, Hochman JS. Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. Am Heart J 2011;162:268-75. [PMID: 21835287 DOI: 10.1016/j.ahj.2011.04.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
54 Bukhari S, Fatima S, Elgendy IY. Cardiogenic shock in the setting of acute myocardial infarction: Another area of sex disparity? World J Cardiol 2021; 13(6): 170-176 [PMID: 34194635 DOI: 10.4330/wjc.v13.i6.170] [Reference Citation Analysis]
55 Doshi R, Patel K, Decter D, Jauhar R, Meraj P. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group. Indian Heart J 2018;70 Suppl 1:S90-5. [PMID: 30122245 DOI: 10.1016/j.ihj.2018.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Goldberg RJ, Makam RC, Yarzebski J, McManus DD, Lessard D, Gore JM. Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes 2016;9:117-25. [PMID: 26884615 DOI: 10.1161/CIRCOUTCOMES.115.002359] [Cited by in Crossref: 76] [Cited by in F6Publishing: 31] [Article Influence: 15.2] [Reference Citation Analysis]
57 Rasche S, Georgi C. [Cardiogenic shock]. Anaesthesist 2012;61:259-72; quiz 273-4. [PMID: 22430557 DOI: 10.1007/s00101-012-1986-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Janssens U. [Cardiogenic shock after acute myocardial infarction]. Internist (Berl) 2006;47:383-4, 386-8. [PMID: 16496103 DOI: 10.1007/s00108-006-1586-y] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Vanzetto G, Akret C, Bach V, Barone G, Durand M, Chavanon O, Hacini R, Bouvaist H, Machecourt J, Blin D. [Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients]. Can J Cardiol 2009;25:e179-86. [PMID: 19536387 DOI: 10.1016/s0828-282x(09)70093-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 3] [Article Influence: 3.2] [Reference Citation Analysis]
60 Kite TA, Ludman PF, Gale CP, Wu J, Caixeta A, Mansourati J, Sabate M, Jimenez-Quevedo P, Candilio L, Sadeghipour P, Iniesta AM, Hoole SP, Palmer N, Ariza-Solé A, Namitokov A, Escutia-Cuevas HH, Vincent F, Tica O, Ngunga M, Meray I, Morrow A, Arefin MM, Lindsay S, Kazamel G, Sharma V, Saad A, Sinagra G, Sanchez FA, Roik M, Savonitto S, Vavlukis M, Sangaraju S, Malik IS, Kean S, Curzen N, Berry C, Stone GW, Gersh BJ, Gershlick AH; International COVID-ACS Registry Investigators. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol 2021;77:2466-76. [PMID: 34016259 DOI: 10.1016/j.jacc.2021.03.309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Fuernau G, Pöss J, Denks D, Desch S, Heine GH, Eitel I, Seiler S, de Waha S, Ewen S, Link A, Schuler G, Adams V, Böhm M, Thiele H. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Crit Care 2014;18:713. [PMID: 25528363 DOI: 10.1186/s13054-014-0713-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
62 Khalid L, Dhakam SH. A review of cardiogenic shock in acute myocardial infarction. Curr Cardiol Rev. 2008;4:34-40. [PMID: 19924275 DOI: 10.2174/157340308783565456] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
63 Link A. [Angiopoietin-2: prognostic parameter in cardiogenic shock]. Med Klin Intensivmed Notfmed 2014;109:69-70. [PMID: 24357108 DOI: 10.1007/s00063-013-0329-9] [Reference Citation Analysis]
64 Kundu A, O'Day K, Shaikh AY, Lessard DM, Saczynski JS, Yarzebski J, Darling CE, Thabet R, Akhter MW, Floyd KC, Goldberg RJ, McManus DD. Relation of Atrial Fibrillation in Acute Myocardial Infarction to In-Hospital Complications and Early Hospital Readmission. Am J Cardiol 2016;117:1213-8. [PMID: 26874548 DOI: 10.1016/j.amjcard.2016.01.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
65 Kaddoura R, Elmoheen A, Badawy E, Eltawagny MF, Seif MA, Bashir K, Salam AM. Vasoactive pharmacologic therapy in cardiogenic shock: a critical review. J Drug Assess 2021;10:68-85. [PMID: 34350058 DOI: 10.1080/21556660.2021.1930548] [Reference Citation Analysis]
66 Subban V, Gnanaraj A, Gomathi B, Janakiraman E, Pandurangi U, Kalidoss L, Ajit SM. Percutaneous coronary intervention in cardiogenic shock complicating acute ST-elevation myocardial infarction-a single centre experience. Indian Heart J 2012;64:152-8. [PMID: 22572491 DOI: 10.1016/S0019-4832(12)60052-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Cosentino N, Resta ML, Somaschini A, Campodonico J, D'Aleo G, Di Stefano G, Lucci C, Moltrasio M, Bonomi A, Cornara S, Demarchi A, De Ferrari G, Bartorelli AL, Marenzi G. ST-Segment Elevation Acute Myocardial Infarction Complicated by Cardiogenic Shock: Early Predictors of Very Long-Term Mortality. J Clin Med 2021;10:2237. [PMID: 34064067 DOI: 10.3390/jcm10112237] [Reference Citation Analysis]
68 Karami M, Hemradj VV, Ouweneel DM, den Uil CA, Limpens J, Otterspoor LC, Vlaar AP, Lagrand WK, Henriques JPS. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E2051. [PMID: 32629772 DOI: 10.3390/jcm9072051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
69 Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, Fonarow GC. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3:e000590. [PMID: 24419737 DOI: 10.1161/jaha.113.000590] [Cited by in Crossref: 222] [Cited by in F6Publishing: 76] [Article Influence: 31.7] [Reference Citation Analysis]
70 Valk SD, Cheng JM, den Uil CA, Lagrand WK, van der Ent M, van de Sande M, van Domburg RT, Simoons ML. Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump. Neth Heart J 2011;19:112-8. [PMID: 21475411 DOI: 10.1007/s12471-010-0066-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
71 Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009;119:1211-9. [PMID: 19237658 DOI: 10.1161/CIRCULATIONAHA.108.814947] [Cited by in Crossref: 432] [Cited by in F6Publishing: 143] [Article Influence: 36.0] [Reference Citation Analysis]